Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Ginseng, the ‘Miracle Root’: How Strong Is the Evidence?

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Weight Down, Steps Down: The GLP-1 Catch

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

What Is Fibermaxxing and Is More Fiber Always Better?

Higher-fiber intake is linked to important health benefits; however, benefits appear to plateau at moderate intake, whereas excessive amounts can cause gastrointestinal symptoms.

Common Lipid-Lowering Drug May Slow Diabetic Eye Damage

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.

Inpatient Weight Loss May Cut HF Rehospitalization Risk

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Sleep Apnoea Tied to Heart Rhythm Risk in Dialysis Patients

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Higher-fiber intake is linked to important health benefits; however, benefits appear to plateau at moderate intake, whereas excessive amounts can cause gastrointestinal symptoms.

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

News All Time

Common ASM Tied to Twofold Thromboembolic Risk With DOACs

Levetiracetam has been linked to an increased thromboembolic risk among adults with epilepsy receiving DOACs, but experts caution that, at this point, the finding is not practice-changing.

An Accordion’s Unlikely Assist in Heart Research

Researchers applied the physics of the instrument to a new device that reproduces the heart’s complex blood flow waveforms.

Doctors Need Friends Outside Medicine, and It’s Not Easy

Doctors may find their closest friends in medicine and have little time for others. But experts say friendships outside the medical bubble matter more than ever.

Mushrooms Gain Ground in Medicine Despite Limited Evidence

Mushroom compounds show potential across cancer, metabolic, and neurologic research, but most evidence remains preclinical and larger clinical trials are still needed.

Cardioprotection Rarely Used in Adults With Blood Cancers

Few adults on anthracycline chemotherapy for hematologic cancers receive strategies to protect their hearts.

Breakthrough Stroke in AF Linked to Drug Interactions

Patients who experience ischemic stroke despite ongoing oral anticoagulation for atrial fibrillation often have identifiable causes such as drug interactions or non-cardioembolic disease.

Medicine on Screen: 10 Films Doctors May Want to Rewatch

From Alzheimer’s to pandemics, these films show how medicine is lived as much as it is practiced.

Sequential or Simultaneous Therapy in Chronic Kidney Disease

Experts debate the pros and cons of stepwise vs simultaneous therapy for chronic kidney disease in an era of multifactorial treatment choices.

Deep Dive: DPP-4 Inhibitors After the ADA Downgrade

ADA now says limit or discontinue gliptins. Cardiologist Benjamin Scirica, MD, on why sitagliptin still looks safest of the four.

New Tool May Identify Adverse Events in Hospitalized Kids

A new trigger tool can help identify adverse events in hospitalized children, showing good reviewer agreement and aiding the systematic detection of patient harm.

Central Obesity Reveals Hidden Risk in Overweight

Adding waist-based central obesity measures to BMI may improve the identification of risk for multimorbidity in adults with BMI-defined overweight.

Canada Joins Global Call for Exercise Physiology for Obesity

A new joint global statement says that exercise physiologists should be part of a multidisciplinary obesity care team for patients taking weight management medications.

Fitness Changes Over Time Linked to Cardiovascular Risk

In adults, changes in cardiorespiratory fitness over time — not just a single measurement — are linked to their risks for cardiovascular disease and death.

Eating Right, Mediterranean-Style, Boosts Diet Quality

A Mediterranean-style diet helps people lose about 3.5% of their body weight over 2 years — matching a commercial weight-loss program’s results, but with meaningfully better diet quality.

Repeated Syncope in a Woman With No Known Heart Disease

Idiopathic ventricular fibrillation can affect people with no clinical evidence of heart disease

Escalate, Achieve, Optimize: Advancing LDL-C Management in Primary Care

Escalate, Achieve, Optimize: Advancing LDL-C Management in Primary Care

Recommended News For You

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Breast Cancer Incidence Rises in Asian American Women

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

Alcohol Causes Cancer. We Should Be Drinking Less.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

Recommended Articles For You

Managing Delayed Toxicities of Targeted Anticancer Therapies 

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy 

Unraveling the Genetic Mystery of Hereditary Spherocytosis 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

10-year study shows tomosynthesis improves breast cancer detection

2.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

3.

Microplastics can cause malignant changes in lung cells

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Two medications might work better for breast cancers that are resistant to one.

1.

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment

2.

Digital Morphology Libraries for Hematology Education: Transforming Diagnostic Training and Clinical Practice

3.

Iron Metabolism and Inflammatory Disorders: Mechanisms, Clinical Implications, and Therapeutic Approaches

4.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

5.

Tumor Microenvironment Readiness as a Predictor of Cancer Progression

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

4.

Nutrition During Cancer Treatment

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot